<?xml version="1.0" encoding="UTF-8"?>
<sec id="sec2dot3-pharmaceuticals-10-00084" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">2.3. Isolation and Characterization of Acorenone B</div>
 <p xmlns="http://www.w3.org/1999/xhtml">Acorenone B was isolated by column chromatography on silica gel G60 (1 kg). The mixture (5.0 g) was eluted in isocratic condition with hexane-ethyl acetate 90:10. The compound (1.48 g) was obtained as a pale yellow oil, with optical rotation 
  <div class="inline-formula">
   <div id="mm2" class="math">
    <div class="mrow">
     <div class="mrow">
      <div class="msubsup">
       <div class="mrow">
        <div class="mrow">
         <span class="mo">[</span>
         <span class="mo">∝</span>
         <span class="mo">]</span>
        </div>
       </div>
       <span class="mi">D</span>
       <div class="mrow">
        <span class="mn">20</span>
       </div>
      </div>
      <span class="mo">=</span>
      <span class="mo">−</span>
      <span class="mn">17.6</span>
     </div>
    </div>
   </div>
  </div> (CHCl
  <sub>3</sub>; c = 11.4). Results similar to ours were reported by Zalkow [
  <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">The molecular structure of acorenone B (
  <a ref-type="fig" rid="pharmaceuticals-10-00084-f002" href="#pharmaceuticals-10-00084-f002">Figure 2</a>) was confirmed by 
  <span class="sup">1</span>H NMR, 
  <span class="sup">13</span>C NMR, and MS analysis, and compared with data present in the literature [
  <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>,
  <a rid="B25-pharmaceuticals-10-00084" ref-type="bibr" href="#B25-pharmaceuticals-10-00084">25</a>,
  <a rid="B26-pharmaceuticals-10-00084" ref-type="bibr" href="#B26-pharmaceuticals-10-00084">26</a>,
  <a rid="B27-pharmaceuticals-10-00084" ref-type="bibr" href="#B27-pharmaceuticals-10-00084">27</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">
  <span class="sup">1</span>H NMR (400 MHz, CDCl
  <sub>3</sub>), δ (ppm): 0.74 (3H, d, 
  <span class="italic">J</span> = 6.8 Hz, CH
  <sub>3</sub> of isopropyl), 0.83 (3H, d, 
  <span class="italic">J</span> = 6.8 Hz, CH
  <sub>3</sub> of isopropyl), 0.92 (3H, d, 
  <span class="italic">J</span> = 6.4 Hz, 4-CH
  <sub>3</sub>), 1.73 (3H, m, 8-CH
  <sub>3</sub>), 2.04 (1H, m, H-10), 2.20 (1H, m, H-6) 2.27 (1H, m, H-10), 2.67 (1H, m, H-6), 6.62 (1H, m, H-9).
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">
  <span class="sup">13</span>C NMR (100 MHz, CDCl
  <sub>3</sub>), δ (ppm): 200.6 (C-7), 144.4 (C-9), 135.4 (C-8), 56.9 (C-1), 49.4 (C-6), 48.4 (C-5), 46.1 (C-4), 29.8 (C-3), 29.2 (C-11), 26.0 (C-10), 25.3 (C-2), 24.2 (C-13), 21.4 (C-14), 17.1 (C-12), 15.6 (C-15).
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">EI-MS 
  <span class="italic">m</span>/
  <span class="italic">z</span> (%): 220 (M+, 58), 177 (76), 149 (45), 135 (100), 121 (60), 109 (100), 93 (46), 82 (84), 69 (28), 55 (22), 41 (29).
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">In our study, the fractionation of the essential oil of 
  <span class="italic">Niphogeton dissecta</span> afforded a pure sequiterpene: acorenone B. Several authors reported the occurrence of acorenone B in other volatile fractions, such as the ones of 
  <span class="italic">Bothriochloa intermedia</span> (47%) [
  <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>], 
  <span class="italic">Bothriochloa pertusa</span> (9.8%) [
  <a rid="B28-pharmaceuticals-10-00084" ref-type="bibr" href="#B28-pharmaceuticals-10-00084">28</a>], 
  <span class="italic">Chaerophyllum hirsutum</span> (9.47% to 18.49%) [
  <a rid="B26-pharmaceuticals-10-00084" ref-type="bibr" href="#B26-pharmaceuticals-10-00084">26</a>], 
  <span class="italic">Euphorbia macrorrhiza</span> (16.72% and 25.80%) [
  <a rid="B29-pharmaceuticals-10-00084" ref-type="bibr" href="#B29-pharmaceuticals-10-00084">29</a>], 
  <span class="italic">Levisticum persicum</span> (8.3% to 12.6%) [
  <a rid="B30-pharmaceuticals-10-00084" ref-type="bibr" href="#B30-pharmaceuticals-10-00084">30</a>], and as a major compound in 
  <span class="italic">Daucus littoralis subsp. Hyrcanicus</span> (19.7% to 57.5% in all parts) [
  <a rid="B31-pharmaceuticals-10-00084" ref-type="bibr" href="#B31-pharmaceuticals-10-00084">31</a>], and 
  <span class="italic">Bothriochloa bladhii</span> (18.2%) [
  <a rid="B32-pharmaceuticals-10-00084" ref-type="bibr" href="#B32-pharmaceuticals-10-00084">32</a>].
 </p>
 <p xmlns="http://www.w3.org/1999/xhtml">The occurrence of acorenone B in 
  <span class="italic">N. dissecta</span> oil appears somewhat unusual because of the diversity of the sesquiterpenoid skeleton involved. According to Zalkow et al. [
  <a rid="B24-pharmaceuticals-10-00084" ref-type="bibr" href="#B24-pharmaceuticals-10-00084">24</a>], the proposed structure of acorenone B is considered to be derived from 
  <span class="italic">trans</span>–
  <span class="italic">cis</span>-farnesol via the β-bisabolyl cation.
 </p>
</sec>
